Position history for Qube Research & Technologies Ltd's holdings in ALNYLAM PHARMACEUTICALS INC
Qube Research & Technologies Ltd holds 774,676 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $308M as of 2025-Q4. The position was decreased (-4.5% shares). ALNY represents 0.3% of Qube Research & Technologies Ltd's portfolio.
Current Value
$308M
Current Shares
774,676
Total Value Change
+$308M
Total Shares Change
+774,676
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 774,676 |
-4.5% |
| $308M |
| 0.3% |
| $397.25 |
0 |
| 2025-Q3 | New | 811,278 | - | $369.9M | 0.4% | $447.49 | 51 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $322.83 | 0 |
| 2025-Q1 | Decreased | 330,347 | -31.9% | $89.2M | 0.1% | $268.46 | 0 |
| 2024-Q4 | Increased | 485,260 | +218.9% | $114.2M | 0.1% | $236.01 | 58 |
| 2024-Q3 | New | 152,162 | - | $41.8M | 0.1% | $274.91 | 40 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $243.00 | 0 |